Open-Label Study of a Twice-Daily Indinavir 800-mg/Ritonavir 200-mg Regimen in HIV-Infected Adults Failing a Protease Inhibitor Regimen.
Autor: | Katner, Harold P., Paar, David P., Jensen, Erin H., Wilson, Helene M., Finn, Tyler S., Petruschke, Richard A., Zeldin, Robert K. |
---|---|
Zdroj: | JAIDS: Journal of Acquired Immune Deficiency Syndromes; 12/15/2002, Vol. 31 Issue 5, p483, 5p, 3 Charts, 5 Graphs |
Databáze: | Complementary Index |
Externí odkaz: |